US Stock MarketDetailed Quotes

GYRE Gyre Therapeutics

Watchlist

13.020
-0.820-5.92%

Trading Nov 15 09:34 ET

1.12BMarket Cap-8917P/E (TTM)

Gyre Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-221.18%-5.49M

-72.31%2.88M

142.50%25.89M

4.53M

15.80%10.42M

-48.56%10.68M

20.76M

Net income from continuing operations

20.37%4.54M

135.59%9.94M

-2,081.46%-85.48M

--3.77M

-46.83%4.22M

-85.43%4.31M

--7.93M

--29.6M

Operating gains losses

-2,807.77%-2.79M

-1,332.36%-4.23M

5,371.76%13.95M

--103K

8,986.21%343K

197.45%255K

--3.77K

---261.68K

Depreciation and amortization

-25.16%238K

48.60%425K

-1.33%1.11M

--318K

-41.53%286K

-41.45%1.13M

--489.17K

--1.93M

Deferred tax

57.83%-97K

4.57%-313K

-38.42%-1.16M

---230K

---328K

---838K

----

Other non cash items

-26.32%-120K

-2,387.50%-183K

36,531.42%82.79M

---95K

3.80%8K

128.66%226K

--7.71K

--98.84K

Change In working capital

-1,224.05%-7.39M

-146.31%-2.76M

195.65%7.46M

--657K

610.33%5.95M

-45.72%-7.8M

--838.2K

---5.35M

-Change in receivables

-622.03%-3.28M

-99.97%1K

116.44%1.3M

---454K

904.73%3.92M

-304.83%-7.92M

---486.5K

---1.96M

-Change in inventory

-714.53%-719K

-226.86%-666K

298.75%1.75M

--117K

29.42%525K

63.70%-879K

--405.65K

---2.42M

-Change in prepaid assets

-2,956.52%-657K

-124.78%-1.52M

-108.43%-82K

--23K

47.55%-678K

191.26%973K

---1.29M

---1.07M

-Change in payables and accrued expense

-501.17%-4.46M

-114.35%-445K

1,006.11%5.07M

--1.11M

40.26%3.1M

82.92%458K

--2.21M

--250.39K

-Change in other current liabilities

1,326.95%1.73M

86.48%-123K

-34.03%-575K

---141K

---910K

---429K

----

-Change in other working capital

----

---157.36K

Cash from discontinued investing activities

Operating cash flow

-221.18%-5.49M

-72.31%2.88M

142.50%25.89M

--4.53M

15.80%10.42M

-48.56%10.68M

--9M

--20.76M

Investing cash flow

Cash flow from continuing investing activities

-2.76%-8.27M

5.60%-7.22M

-43.04%-19.76M

-8.05M

-144.94%-7.65M

-68.65%-13.81M

-3.12M

-8.19M

Net PPE purchase and sale

47.16%-1.24M

89.61%-181K

-57.53%-7.85M

---2.34M

-197.80%-1.74M

-352.63%-4.99M

---584.96K

---1.1M

Net intangibles purchase and sale

--0

-430.77%-69K

---1K

97.44%-65K

99.82%-13K

---2.54M

---7.33M

Net business purchase and sale

----

401.88%4.02M

----

---1.33M

----

Net investment purchase and sale

-23.27%-7.04M

-20.51%-7.04M

-110.25%-15.74M

---5.71M

---5.84M

-3,221.97%-7.48M

----

--239.72K

Net other investing changes

----

---124K

----

Cash from discontinued investing activities

Investing cash flow

-2.76%-8.27M

5.60%-7.22M

-43.04%-19.76M

---8.05M

-144.94%-7.65M

-68.65%-13.81M

---3.12M

---8.19M

Financing cash flow

Cash flow from continuing financing activities

156K

658K

2.5M

-127.88K

-6.83M

Net issuance payments of debt

----

---114.19K

---6.7M

Net preferred stock issuance

----

--2.5M

----

--0

----

Cash dividends paid

----

--0

Proceeds from stock option exercised by employees

--275K

--658K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

--156K

--658K

--2.5M

--0

---127.88K

---6.83M

Net cash flow

Beginning cash position

5.83%29.79M

33.10%33.51M

-16.65%25.18M

--28.14M

-3.75%25.18M

48.42%30.2M

--26.16M

--20.35M

Current changes in cash

-286.87%-13.61M

-232.83%-3.68M

375.17%8.63M

---3.52M

-51.80%2.77M

-154.65%-3.14M

--5.75M

--5.74M

Effect of exchange rate changes

91.33%-78K

-123.00%-46K

84.24%-298K

---900K

--200K

---1.89M

----

End cash Position

-32.15%16.1M

5.83%29.79M

33.10%33.51M

--23.73M

-11.78%28.14M

-3.50%25.18M

--31.9M

--26.09M

Free cash flow

-438.15%-6.95M

-69.19%2.65M

204.74%17.31M

--2.06M

46.60%8.61M

-53.84%5.68M

--5.87M

--12.3M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-221.18%-5.49M	-72.31%2.88M	142.50%25.89M	4.53M	15.80%10.42M	-48.56%10.68M	9M	20.76M
Net income from continuing operations	20.37%4.54M	135.59%9.94M	-2,081.46%-85.48M	--3.77M	-46.83%4.22M	-85.43%4.31M	--7.93M	--29.6M
Operating gains losses	-2,807.77%-2.79M	-1,332.36%-4.23M	5,371.76%13.95M	--103K	8,986.21%343K	197.45%255K	--3.77K	---261.68K
Depreciation and amortization	-25.16%238K	48.60%425K	-1.33%1.11M	--318K	-41.53%286K	-41.45%1.13M	--489.17K	--1.93M
Deferred tax	57.83%-97K	4.57%-313K	-38.42%-1.16M	---230K	---328K	---838K	----	----
Other non cash items	-26.32%-120K	-2,387.50%-183K	36,531.42%82.79M	---95K	3.80%8K	128.66%226K	--7.71K	--98.84K
Change In working capital	-1,224.05%-7.39M	-146.31%-2.76M	195.65%7.46M	--657K	610.33%5.95M	-45.72%-7.8M	--838.2K	---5.35M
-Change in receivables	-622.03%-3.28M	-99.97%1K	116.44%1.3M	---454K	904.73%3.92M	-304.83%-7.92M	---486.5K	---1.96M
-Change in inventory	-714.53%-719K	-226.86%-666K	298.75%1.75M	--117K	29.42%525K	63.70%-879K	--405.65K	---2.42M
-Change in prepaid assets	-2,956.52%-657K	-124.78%-1.52M	-108.43%-82K	--23K	47.55%-678K	191.26%973K	---1.29M	---1.07M
-Change in payables and accrued expense	-501.17%-4.46M	-114.35%-445K	1,006.11%5.07M	--1.11M	40.26%3.1M	82.92%458K	--2.21M	--250.39K
-Change in other current liabilities	1,326.95%1.73M	86.48%-123K	-34.03%-575K	---141K	---910K	---429K	----	----
-Change in other working capital	----	----	----	----	----	----	----	---157.36K
Cash from discontinued investing activities
Operating cash flow	-221.18%-5.49M	-72.31%2.88M	142.50%25.89M	--4.53M	15.80%10.42M	-48.56%10.68M	--9M	--20.76M
Investing cash flow
Cash flow from continuing investing activities	-2.76%-8.27M	5.60%-7.22M	-43.04%-19.76M	-8.05M	-144.94%-7.65M	-68.65%-13.81M	-3.12M	-8.19M
Net PPE purchase and sale	47.16%-1.24M	89.61%-181K	-57.53%-7.85M	---2.34M	-197.80%-1.74M	-352.63%-4.99M	---584.96K	---1.1M
Net intangibles purchase and sale	--0	--0	-430.77%-69K	---1K	97.44%-65K	99.82%-13K	---2.54M	---7.33M
Net business purchase and sale	----	----	401.88%4.02M	----	----	---1.33M	----	----
Net investment purchase and sale	-23.27%-7.04M	-20.51%-7.04M	-110.25%-15.74M	---5.71M	---5.84M	-3,221.97%-7.48M	----	--239.72K
Net other investing changes	----	----	---124K	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	-2.76%-8.27M	5.60%-7.22M	-43.04%-19.76M	---8.05M	-144.94%-7.65M	-68.65%-13.81M	---3.12M	---8.19M
Financing cash flow
Cash flow from continuing financing activities	156K	658K	2.5M	0	0	0	-127.88K	-6.83M
Net issuance payments of debt	----	----	----	----	----	----	---114.19K	---6.7M
Net preferred stock issuance	----	----	--2.5M	----	----	--0	----	----
Cash dividends paid	----	----	----	----	----	----	--0	--0
Proceeds from stock option exercised by employees	--275K	--658K	----	--0	--0	----	----	----
Cash from discontinued financing activities
Financing cash flow	--156K	--658K	--2.5M	--0	--0	--0	---127.88K	---6.83M
Net cash flow
Beginning cash position	5.83%29.79M	33.10%33.51M	-16.65%25.18M	--28.14M	-3.75%25.18M	48.42%30.2M	--26.16M	--20.35M
Current changes in cash	-286.87%-13.61M	-232.83%-3.68M	375.17%8.63M	---3.52M	-51.80%2.77M	-154.65%-3.14M	--5.75M	--5.74M
Effect of exchange rate changes	91.33%-78K	-123.00%-46K	84.24%-298K	---900K	--200K	---1.89M	----	----
End cash Position	-32.15%16.1M	5.83%29.79M	33.10%33.51M	--23.73M	-11.78%28.14M	-3.50%25.18M	--31.9M	--26.09M
Free cash flow	-438.15%-6.95M	-69.19%2.65M	204.74%17.31M	--2.06M	46.60%8.61M	-53.84%5.68M	--5.87M	--12.3M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data